Exact Mass: 440.2212
Exact Mass Matches: 440.2212
Found 500 metabolites which its exact mass value is equals to given mass value 440.2212
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Tirofiban
Tirofiban prevents the blood from clotting during episodes of chest pain or a heart attack, or while the patient is undergoing a procedure to treat a blocked coronary artery. It is a non-peptide reversible antagonist of the platelet glycoprotein (GP) IIb/IIIa receptor, and inhibits platelet aggregation. B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AC - Platelet aggregation inhibitors excl. heparin COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents D050299 - Fibrin Modulating Agents D002317 - Cardiovascular Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
3'-Hydroxy-HT2 toxin
3-Hydroxy-HT2 toxin is a mycotoxin from Fusarium heterosporu Mycotoxin from Fusarium heterosporum
4-(5-Chloro-3-isopropyl-1H-pyrazol-4-yl)-N-(5-(4-(dimethylamino)piperidin-1-yl)pyridin-2-yl)pyrimidin-2-amine
3-[2-[[(1S,2R,3S)-3-[4-(Pentylcarbamoyl)-1,3-oxazol-2-yl]-7-oxabicyclo[2.2.1]heptan-2-yl]methyl]phenyl]propanoic acid
Ceranapril
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
Nemiralisib
D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors C78273 - Agent Affecting Respiratory System
5,7-Dihydroxy-4-methoxy-8-C-prenyl-3-(3-hydroxy-3-methylbutyl)flavanone
3-Geranyl-3,4,2,4-tetrahydroxy-6-methoxydihydrochalcone
3,2,4,6-Tetrahydroxy-4-methoxy-3,5-diprenyldihydrochalcone
1-[(2,2-Dimethyl-5,7-dihydroxy-3,4-dihydro-2H-1-benzopyran)-6-yl]-3-[3-hydroxy-4-methoxy-5-(3-methyl-2-butenyl)phenyl]-1-propanone
cis-1-(2,4,5-trimethoxy-E-styryl)-2-(2,4,5-trimethoxy-Z-styryl)cyclobutane|trans-1-(2,4,5-trimethoxy-E-styryl)-2-(2,4,5-trimethoxy-Z-styryl)cyclobutane
methyl-[O2,O4-dimethyl-O6-(tetra-O-methyl-beta-D-galactopyranosyl)-xi-D-galactopyranoside]|Methyl-[O2,O4-dimethyl-O6-(tetra-O-methyl-beta-D-galactopyranosyl)-xi-D-galactopyranosid]
(9R,9aR)-9-hydroxy-9a-methyl-3-octanoyl-9-(2-oxopropyl)-6-((E)-prop-1-enyl)-9,9a-dihydro-2H-furo[3,2-g]isochromen-2-one|monaphilol C
9-hydroxy-1-methoxy-8-(3-hydroxy-3-methylbutyl)-6,6-dimethyl-4,5-dihydro-[6H]-pyrano[2,3:3,2]-pterocarpan|glycycarpan
(3alpha,4beta,8alpha)-4-(acetyloxy)-3-(2,3-dihydroxy-2-methyl-1-oxobutoxy)-8-hydroxyeudesm-7(11)-eno-12,8-lactone|rel-(4aR,5S,6R,8aR,9aS)-5-(acetyloxy)-9a-hydroxy-3,5,8a-trimethyl-2-oxo-2,4,4a,5,6,7,8,8a,9,9a-decahydronaphtho[2,3-b]furan-6-yl 2,3-dihydroxy-2-methylbutanoate
6-hydroxy-8-(2-hydroxy-4-methoxy-6-pentylphenoxy)-3-pentylisochromen-1-one
2(S)-5,7,4-trihydroxy-6-methyl-3-[7-hydroxy-3,7-dimethyl-2(E)-octenyl]flavanone|hirtellanine G
6-Me ether-3-(3,4-Dihydroxyphenyl)-1-[3-(3,7-dimethyl-2,6-octadienyl)-2,4,6-trihydroxyphenyl]-1-propanone
6-Deoxy-2-O-alpha-L-rhamnopyranosyl-L-talose-Benzyl glycoside, 3,4-O-isopropylidene
3-Ketone-(3alpha,5alpha,9alpha,10beta)-7-O-(3-Hydroxy-7-drimen-11-yl)isofraxidin
(1S,4aS,8aR)-7-[(decahydro-5,5,8a-trimethyl-2-methylene-6-oxo-1-naphthalenyl)methoxy]-6,8-dimethoxy-2H-1-benzopyran-2-one
7-hydroxy-2-methyl-2-(4-methylpent-3-enyl)-4-(1-hydroxypropyl)-8-(1-oxobutyl)-2H,8H-benzo[1,2-b:3,4-b]dipyran-2-one|kayeassamin I
Ala His Val Asp
His Ala Val Asp
C27H28N4O2_(3S,6S)-3-(1H-Indol-3-ylmethyl)-6-{[2-(2-methyl-3-buten-2-yl)-1H-indol-3-yl]methyl}-2,5-piperazinedione
C19H36O11_beta-D-Glucopyranoside, 3-ethyl-4-hydroxy-4-methylpentyl 6-O-[(2S,3R,4R)-tetrahydro-3,4-dihydroxy-4-(hydroxymethyl)-2-furanyl]
Ala Asp His Val
Ala Asp Val His
Ala Phe Phe Gly
Ala Phe Gly Phe
Ala Gly Phe Phe
Ala His Asp Val
Ala His Ile Thr
Ala His Leu Thr
Ala His Thr Ile
Ala His Thr Leu
Ala Ile His Thr
Ala Ile Thr His
Ala Leu His Thr
Ala Leu Thr His
Ala Thr His Ile
Ala Thr His Leu
Ala Thr Ile His
Ala Thr Leu His
Ala Val Asp His
Ala Val His Asp
Asp Ala His Val
Asp Ala Val His
Asp Gly His Ile
Asp Gly His Leu
Asp Gly Ile His
Asp Gly Leu His
Asp His Ala Val
Asp His Gly Ile
Asp His Gly Leu
Asp His Ile Gly
Asp His Leu Gly
Asp His Val Ala
Asp Ile Gly His
Asp Ile His Gly
Asp Ile Pro Pro
Asp Leu Gly His
Asp Leu His Gly
Asp Leu Pro Pro
Asp Pro Ile Pro
Asp Pro Leu Pro
Asp Pro Pro Ile
Asp Pro Pro Leu
Glu His Gly Val
Glu Pro Pro Val
Glu Pro Val Pro
Glu Val Gly His
Glu Val His Gly
Glu Val Pro Pro
Phe Ala Phe Gly
Phe Ala Gly Phe
Phe Phe Ala Gly
Phe Phe Gly Ala
Phe Gly Ala Phe
Phe Gly Phe Ala
Gly Ala Phe Phe
Gly Asp His Ile
Gly Asp His Leu
Gly Asp Ile His
Gly Asp Leu His
Gly Glu His Val
Gly Glu Val His
Gly Phe Ala Phe
Gly Phe Phe Ala
Gly His Asp Ile
Gly His Asp Leu
Gly His Glu Val
Gly His Ile Asp
Gly His Leu Asp
Gly His Val Glu
Gly Ile Asp His
Gly Ile His Asp
Gly Leu Asp His
Gly Leu His Asp
Gly Val Glu His
Gly Val His Glu
His Ala Asp Val
His Ala Ile Thr
His Ala Leu Thr
His Ala Thr Ile
His Ala Thr Leu
His Asp Ala Val
His Asp Gly Ile
His Asp Gly Leu
His Asp Ile Gly
His Asp Leu Gly
His Asp Val Ala
His Glu Gly Val
His Glu Val Gly
His Gly Asp Ile
His Gly Asp Leu
His Gly Glu Val
His Gly Ile Asp
His Gly Leu Asp
His Gly Val Glu
His Ile Ala Thr
His Ile Asp Gly
His Ile Gly Asp
His Ile Thr Ala
His Leu Ala Thr
His Leu Asp Gly
His Leu Gly Asp
His Leu Thr Ala
His Pro Ser Thr
His Pro Thr Ser
His Ser Pro Thr
His Ser Thr Pro
His Ser Val Val
His Thr Ala Ile
His Thr Ala Leu
His Thr Ile Ala
His Thr Leu Ala
His Thr Pro Ser
His Thr Ser Pro
His Val Ala Asp
His Val Asp Ala
His Val Glu Gly
His Val Gly Glu
His Val Ser Val
His Val Val Ser
Ile Ala His Thr
Ile Ala Thr His
Ile Asp Gly His
Ile Asp His Gly
Ile Asp Pro Pro
Ile Gly Asp His
Ile Gly His Asp
Ile His Ala Thr
Ile His Asp Gly
Ile His Gly Asp
Ile His Thr Ala
Ile Pro Asp Pro
Ile Pro Pro Asp
Ile Thr Ala His
Ile Thr His Ala
Leu Ala His Thr
Leu Ala Thr His
Leu Asp Gly His
Leu Asp His Gly
Leu Asp Pro Pro
Leu Gly Asp His
Leu Gly His Asp
Leu His Ala Thr
Leu His Asp Gly
Leu His Gly Asp
Leu His Thr Ala
Leu Pro Asp Pro
Leu Pro Pro Asp
Leu Thr Ala His
Leu Thr His Ala
Met Pro Pro Pro
Asn Asn Pro Pro
Asn Pro Asn Pro
Asn Pro Pro Asn
Pro Asp Ile Pro
Pro Asp Leu Pro
Pro Asp Pro Ile
Pro Asp Pro Leu
Pro Glu Pro Val
Pro Glu Val Pro
Pro His Ser Thr
Pro His Thr Ser
Pro Ile Asp Pro
Pro Ile Pro Asp
Pro Leu Asp Pro
Pro Leu Pro Asp
Pro Met Pro Pro
Pro Asn Asn Pro
Pro Asn Pro Asn
Pro Pro Asp Ile
Pro Pro Asp Leu
Pro Pro Glu Val
Pro Pro Ile Asp
Pro Pro Leu Asp
Pro Pro Met Pro
Pro Pro Asn Asn
Pro Pro Pro Met
Pro Pro Val Glu
Pro Ser His Thr
Pro Ser Thr His
Pro Thr His Ser
Pro Thr Ser His
Pro Val Glu Pro
Pro Val Pro Glu
Ser His Pro Thr
Ser His Thr Pro
Ser His Val Val
Ser Pro His Thr
Ser Pro Thr His
Ser Thr His Pro
Ser Thr Pro His
Ser Val His Val
Ser Val Val His
Thr Ala His Ile
Thr Ala His Leu
Thr Ala Ile His
Thr Ala Leu His
Thr His Ala Ile
Thr His Ala Leu
Thr His Ile Ala
Thr His Leu Ala
Thr His Pro Ser
Thr His Ser Pro
Thr Ile Ala His
Thr Ile His Ala
Thr Leu Ala His
Thr Leu His Ala
Thr Pro His Ser
Thr Pro Ser His
Thr Ser His Pro
Thr Ser Pro His
Val Ala Asp His
Val Ala His Asp
Val Asp Ala His
Val Asp His Ala
Val Glu Pro Pro
Val His Ser Val
Val His Val Ser
Val Pro Glu Pro
Val Pro Pro Glu
Val Ser His Val
Val Ser Val His
Val Val His Ser
Val Val Ser His
1-(2-(DI-TERT-BUTYLPHOSPHINO)PHENYL)-3,5-DIPHENYL-1H-PYRAZOLE
Ifetroban
C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors
Ceronapril
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
Benzyl 7-(diphenylmethyl)-6-oxo-1,7-diazaspiro[4.4]nonane-1-carbo xylate
BIX 02189
BIX02189 is a potent and selective MEK5 inhibitor with an IC50 of 1.5 nM. BIX02189 also inhibits ERK5 catalytic activity with an IC50 of 59 nM.
Trans-1-[4-(4-heptylcyclohexyl)phenoxy]-2,4-dinitro benzene
1-N,4-N-bis(4-methylphenyl)-1-N,4-N-diphenylbenzene-1,4-diamine
Flumedroxone acetate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
Glycycarpan
A member of the class of pterocarpan that is a cis-pterocarpan substituted by a hydroxy group at position 9, a 3-hydroxy-3-methylbutyl group at position 8, a methoxy group at position 1 and a dimethylpyran ring fused across positions 2 and 3. It has been isolated from Glycyrrhiza uralensis.
5-[2-(3,4-dihydro-2H-quinolin-1-yl)-2-oxoethoxy]-2-[(3-methylphenyl)methyl]-3,4-dihydroisoquinolin-1-one
Methyl-[4-(4-piperidine-1-ylmethyl-phenyl)-cyclohexyl]-carbaminic acid-(4-chlorophenyl)-ester
Nemiralisib
D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors C78273 - Agent Affecting Respiratory System
16-[(2R)-1-hydroxy-3-phosphonooxypropan-2-yl]oxy-16-oxohexadecanoic acid
16-[(2R)-2-hydroxy-3-phosphonooxypropoxy]-16-oxohexadecanoic acid
methyl (1R,9S,10S,11S)-12-(cyclopentylmethyl)-5-(2-fluorophenyl)-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylate
methyl (1R,9S,10S,11S)-12-(cyclohexanecarbonyl)-5-(cyclopenten-1-yl)-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylate
(1S,9R,10R,11R)-12-(cyclohexylmethyl)-5-(4-fluorophenyl)-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylic acid
(1R,9S,10S,11S)-12-(cyclohexylmethyl)-5-(4-fluorophenyl)-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylic acid
methyl N-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
methyl N-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
methyl N-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
methyl N-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
methyl N-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
methyl (1S,9R,10R,11R)-12-(cyclopentylmethyl)-5-(2-fluorophenyl)-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylate
methyl N-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
methyl N-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
1-[2,4-Dihydroxy-5-(3-methylbut-2-enyl)phenyl]-2-hydroxy-3-[4-hydroxy-3-methoxy-5-(3-methylbut-2-enyl)phenyl]propan-1-one
[3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (Z)-tridec-9-enoate
Tirofiban
B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AC - Platelet aggregation inhibitors excl. heparin COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents D050299 - Fibrin Modulating Agents D002317 - Cardiovascular Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
7-deacetylgedunin
A limonoid that is the 7-deacetyl derivative of gedunin. It has been isolated from Azadirachta indica.
3-(3,4-dihydroxyphenyl)-1-{3-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-2,4-dihydroxy-6-methoxyphenyl}propan-1-one
1-(furan-3-yl)-4,6-dihydroxy-3b,9a,11a-trimethyl-9-oxo-1h,2h,4h,5h,5ah,6h,9bh,10h,11h-cyclopenta[a]phenanthren-5-yl acetate
(2-hydroxy-1,4a-dimethyl-6-methylidene-5-{[(2-oxochromen-7-yl)oxy]methyl}-hexahydro-2h-naphthalen-1-yl)methyl acetate
6-butanoyl-5-hydroxy-10-(1-hydroxypropyl)-2-methyl-2-(4-methylpent-3-en-1-yl)pyrano[2,3-h]chromen-8-one
7-(furan-3-yl)-19-hydroxy-1,8,12,16,16-pentamethyl-3,6-dioxapentacyclo[9.8.0.0²,⁴.0²,⁸.0¹²,¹⁷]nonadec-13-ene-5,15-dione
(2r)-2-[(1r,4as,7s,7ar)-4,7-dimethyl-3-(3-methylbutanoyl)-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-1-yl]-4-methyl-3-oxo-1-benzofuran-2-yl acetate
methyl (1r,9r,15r,16s,18r,21r)-2-acetyl-4,15-dimethoxy-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7-triene-18-carboxylate
(2s)-2-{4-[(3,6-dimethylhept-2-en-1-yl)oxy]-3-methoxyphenyl}-5-hydroxy-7-methoxy-2,3-dihydro-1-benzopyran-4-one
8-hydroxy-3,7,11-trimethyl-1-[(2-oxochromen-7-yl)oxy]dodeca-2,6,10-trien-5-yl acetate
3-(1h-indol-3-ylmethyl)-6-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-3,6-dihydropyrazine-2,5-diol
[(1r,2r,4ar,5r,8as)-2-hydroxy-1,4a-dimethyl-6-methylidene-5-{[(2-oxochromen-7-yl)oxy]methyl}-hexahydro-2h-naphthalen-1-yl]methyl acetate
methyl 2-[13-(furan-3-yl)-2-hydroxy-4,8,10,12-tetramethyl-7-oxo-16-oxatetracyclo[8.6.0.0³,⁸.0¹¹,¹⁵]hexadeca-4,11-dien-9-yl]acetate
(1r,2r,8r,9r,11r,12r,14r,16s,17s)-16-(furan-3-yl)-9-hydroxy-2,7,7,11,17-pentamethyl-6,13-dioxapentacyclo[9.8.0.0²,⁸.0¹²,¹⁴.0¹²,¹⁷]nonadec-3-ene-5,10-dione
(5r,6e,8r,10e)-8-hydroxy-2,6,10-trimethyl-12-[(2-oxochromen-7-yl)oxy]dodeca-2,6,10-trien-5-yl acetate
1-[(2s)-4,6-dihydroxy-2-(2-hydroxypropan-2-yl)-5-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzofuran-7-yl]-3-(4-methoxyphenyl)propan-1-one
1,2,4-trimethoxy-5-[(1z)-2-[(1s,2r)-2-[(1e)-2-(2,4,5-trimethoxyphenyl)ethenyl]cyclobutyl]ethenyl]benzene
(2e,4e,6e)-8-({2-[(2,3-dihydroxy-3-methylbutanoyl)oxy]-3-methylpentanoyl}oxy)-8-(2-methyloxiran-2-yl)octa-2,4,6-trienoic acid
1,2-bis(2,4,5-trimethoxy-z-styryl)cyclobutane
{"Ingredient_id": "HBIN000763","Ingredient_name": "1,2-bis(2,4,5-trimethoxy-z-styryl)cyclobutane","Alias": "NA","Ingredient_formula": "C26H32O6","Ingredient_Smile": "COC1=CC(=C(C=C1C=CC2CCC2C=CC3=CC(=C(C=C3OC)OC)OC)OC)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21916","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}